Center for Scientific Review; Notice of Closed Meetings, 18570 [2014-07282]
Download as PDF
<![CDATA[
18570
Federal Register / Vol. 79, No. 63 / Wednesday, April 2, 2014 / Notices
Dated: March 25, 2014.
Jessica Schwartz,
NIA Project Clearance Liaison, National
Institutes of Health.
Dated: March 27, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–07391 Filed 4–1–14; 8:45 am]
[FR Doc. 2014–07282 Filed 4–1–14; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
National Institutes of Health
[Docket No. DHS–2014–0012]
Center for Scientific Review; Notice of
Closed Meetings
Public Review of Patient
Decontamination in a Mass Chemical
Exposure Incident: National Planning
Guidance for Communities
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Therapy.
Date: April 25, 2014.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Sally A. Mulhern, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 435–
5877, mulherns@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
190: Detection of Pathogen Induced Cancer.
Date: May 2, 2014.
Time: 11:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mai.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Mar<15>2010
17:01 Apr 01, 2014
Jkt 232001
Office of Health Affairs,
Department of Homeland Security.
ACTION: Notice and request for
comments.
AGENCY:
The Chemical Defense
Program (CDP), under the Department of
Homeland Security Office of Health
Affairs (OHA), and Office of the
Assistant Secretary for Preparedness
and Response (ASPR), under the
Department of Health and Human
Services (HHS), are seeking public
comment on a document titled ‘‘Patient
Decontamination in a Mass Chemical
Exposure Incident: National Planning
Guidance for Communities.’’
DATES: Submit the completed comment
matrix on or before May 19, 2014.
ADDRESSES: Comments may be
submitted, identified by docket number
DHS–2014–0012, by one of the
following methods:
• Federal e-Rulemaking Portal: https://
www.regulations.gov.
Instructions: All submissions received
must include the words ‘‘Department of
Homeland Security and docket number
for this rulemaking. All comments
received will be posted without change
to https://www.regulations.gov, including
any personal information provided.
Docket: For access to the docket to
read background documents or
comments received, please visit https://
www.regulations.gov and type the
docket number (DHS–2014–0012) into
the ‘‘SEARCH for: Rules, Comments,
Adjudications or Supporting
Documents:’’ field in the middle of the
Web site.
SUPPLEMENTARY INFORMATION: This
guidance document is developed for
senior leaders, planners, incident
commanders, emergency management
personnel and trainers of local response
organizations and health care facilities;
it contains strategic-level, evidencebased best practices for use when
planning and conducting patient
decontamination in a mass chemical
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
casualty event. The subject matter is
focused on external decontamination of
living people exposed to toxic industrial
chemicals (TICs), toxic industrial
materials (TIMs) or chemical warfare
agents (CWAs) resulting from either an
intentional or accidental release. The
guidance document provides an
approach that is flexible and scalable
according to the resource and capability
limitations of the organization. The
recommendations, therefore, are
adaptable to each unique community as
it sees fit. The principals set forth in this
guidance document are strategic-level
and designed to guide communities’
planning efforts rather than specify
operational practices. The guidance is
evidence-based using currently
available scientific research to the
extent possible, and the supporting
evidence is documented and briefly
discussed.
FOR FURTHER INFORMATION CONTACT:
Dhs.oha.cdp@hq.dhs.gov
Dated: March 21, 2014.
Mark A. Kirk,
Director, Chemical Defense Program.
[FR Doc. 2014–07392 Filed 4–1–14; 8:45 am]
BILLING CODE 9110–9K–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2014–0212]
Merchant Marine Personnel Advisory
Committee: Intercessional Meeting
Coast Guard, DHS.
Notice of Federal Advisory
Committee working group meeting.
AGENCY:
ACTION:
A working group of the
Merchant Marine Personnel Advisory
Committee (MERPAC) will meet to work
on Task Statement 80, concerning crew
training requirements onboard vessels
subject to the International Code of
Safety for ships using gases or low flashpoint fuels (IGF Code). This meeting
will be open to the public.
DATES: A MERPAC working group will
meet on April 17, 2014, from 8 a.m.
until 4 p.m. Please note that the meeting
may adjourn early if all business is
finished. Written comments to be
distributed to working group members
and placed on MERPAC’s Web site are
due by April 7, 2014.
ADDRESSES: The working group will
meet in Room A129 of the Maritime
Institute of Technology and Graduate
Studies (MITAGS), 692 Maritime
Boulevard, Linthicum Heights, MD
21090. For further information on the
SUMMARY:
E:\FR\FM\02APN1.SGM
02APN1
]]>Agencies
[Federal Register Volume 79, Number 63 (Wednesday, April 2, 2014)]
[Notices]
[Page 18570]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-07282]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Therapy.
Date: April 25, 2014.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Sally A. Mulhern, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD
20892, (301) 435-5877, mulherns@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-13-190: Detection of Pathogen Induced Cancer.
Date: May 2, 2014.
Time: 11:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, 301-435-
1167, pandyaga@mai.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 27, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-07282 Filed 4-1-14; 8:45 am]
BILLING CODE 4140-01-P
